Agalsidase Beta

Common brands: Fabrazyme, Tylenol Extra Strength, Tylenol Regular Strength, Epipen, Pain Relief

Top reporter: Genzyme Corporation

Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Catecholamine [EPC]alpha-Adrenergic Agonist [EPC]beta-Adrenergic Agonist [EPC]
8,974
Total Reports
3,465
Serious Reports
693
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.72%)

Patient Demographics

Male
4,997
Female
3,284

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Agalsidase Beta.

# Reaction Reports % of Total
1 PYREXIA 517
5.9%
2 PAIN 498
5.7%
3 MALAISE 482
5.5%
4 CHILLS 474
5.4%
5 NAUSEA 459
5.3%
6 FATIGUE 419
4.8%
7 DYSPNOEA 409
4.7%
8 HEADACHE 368
4.2%
9 VOMITING 365
4.2%
10 WEIGHT DECREASED 328
3.8%
11 PAIN IN EXTREMITY 307
3.5%
12 INFUSION RELATED REACTION 297
3.4%
13 DIZZINESS 271
3.1%
14 WEIGHT INCREASED 262
3.0%
15 CONDITION AGGRAVATED 256
2.9%
16 COUGH 256
2.9%
17 CEREBROVASCULAR ACCIDENT 244
2.8%
18 CHEST PAIN 243
2.8%
19 DIARRHOEA 226
2.6%
20 ILLNESS 207
2.4%
21 ATRIAL FIBRILLATION 204
2.3%
22 PRURITUS 199
2.3%
23 DRUG SPECIFIC ANTIBODY PRESENT 193
2.2%
24 FALL 193
2.2%
25 PARAESTHESIA 180
2.1%
26 COVID-19 175
2.0%
27 CARDIAC DISORDER 172
2.0%
28 PRODUCT DOSE OMISSION ISSUE 170
2.0%
29 URTICARIA 168
1.9%
30 DEATH 164
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.